Drug shortage
Arsenic Trioxide Injection · Ingenus Pharmaceuticals LLC
FDA drug shortage · To Be Discontinued · updated Feb 24, 2026
Key facts
| Generic name | Arsenic Trioxide Injection |
|---|---|
| Company | Ingenus Pharmaceuticals LLC |
| Presentation | Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Oncology |
| Package NDCs | 50742-438-10 |
| First posted | Feb 24, 2026 |
| Last updated | Feb 24, 2026 |
| Discontinued | Feb 24, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: